CME Information
This activity is jointly provided by Global Education Group (Global) and MedliveCME, LLC (previously known as PlatformQ Health Education, LLC), in collaboration with the Pancreatic Cancer Action Network (PanCAN).
Acknowledgement
This activity is supported by an independent medical education grant from Revolution Medicines.
Date of Release/Expiration
This activity was released on February 3rd, 2026, and is valid until February 3rd, 2027. Requests for credit must be made no later than February 3rd, 2027.
Credits Available
- Physicians — maximum of 1.0 AMA PRA Category 1 Credit(s)™
All other healthcare professionals completing this course will be issued a statement of participation.
Target Audience
The educational design of this activity addresses the needs of oncologists and gastroenterologists, including APPs.
Program Overview
Pancreatic ductal adenocarcinoma (PDAC) remains one of the most lethal cancers, with limited therapeutic options and persistently poor survival outcomes. As advances in molecular profiling uncover actionable genomic alterations – including KRAS-targeted approaches and rare but meaningful biomarkers – oncologists and gastroenterologists face a growing need to integrate precision medicine into routine PDAC care.
“Cracking the Code in PDAC” will equip clinicians with practical, evidence-based strategies to optimize treatment planning for patients with metastatic PDAC. Expert faculty will review the importance of early and comprehensive molecular profiling, examine emerging data on targeted and biomarker-driven therapies, and translate these insights into real-world clinical decision-making. Joining the faculty panel, a patient advocate will highlight supportive care needs and lived experiences of those navigating the PDAC treatment journey. By the end of the activity, clinicians will be prepared to integrate precision oncology approaches while supporting resilience, symptom management, and quality of life for patients facing this high-need disease.
Learning Objectives
After completing this activity, the participant should be better able to:
- Assess the role of early, comprehensive molecular profiling in guiding precision PDAC treatment planning
- Analyze evidence from trials investigating targeted and biomarker-driven therapies in metastatic PDAC
- Examine strategies to support patient resilience and quality of life, with attention to symptom management, psychosocial needs, and multidisciplinary care
Faculty
John Strickler MD
Professor of Medicine
Service Leader- GI Oncology
Duke University School of Medicine
Shubham Pant, MD
Professor of Medicine
Department of Gastrointestinal Medical Oncology
MD Anderson Cancer Center
Anna Berkenblit, MD
Chief Scientific & Medical Officer
Pancreatic Cancer Action Network
Ron Silvestri, MD
Patient Advocate for the Pancreatic Cancer Action Network
Pranathi Perati
Vignette Speaker
Physician Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and MedliveCME, LLC (previously known as PlatformQ Health Education, LLC). Global is accredited by the ACCME to provide continuing medical education for physicians.
Physician Credit Designation
Global Education Group designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Estimated Time to Complete
This activity should take approximately 60 minutes to complete.
Instructions to Receive Credit
In order to receive credit for this activity, the participant must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the post-test and activity evaluation. To receive AMA PRA Category 1 Credits™, participants must receive a score of 70% on the post-test.
Hardware/Software Requirements
Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.
Fee Information & Refund/Cancellation Policy
There is no fee for this educational activity.
Disclosures of Relevant Financial Relationships
Global adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Global are required to disclose all financial relationships with any ineligible company within the past 24 months to Global. All financial relationships reported are identified as relevant and mitigated by Global in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Global to assure objectivity and that the activity is free of commercial bias.
All relevant financial relationships have been mitigated.
The faculty have the following relevant financial relationships with ineligible companies:
The planners and managers at Global Education Group and MedliveCME, LLC (previously known as PlatformQ Health Education, LLC) have no relevant financial relationships to disclose.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global and MedliveCME, LLC (previously known as PlatformQ Health Education, LLC) do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Contact Information
Accreditation Support:
For information about the accreditation of this program, please contact Global at 303-395-1782 or [email protected].
Technical Support:
For any technical issues or issues with your CME Certificate, please contact Medlive at 877-394-1306 or at [email protected].